The hidden danger in Trump’s drug-price plan

biotechnology as a strategic national priority.

Between 2016 and 2021, the market capitalization of Chinese biotechnology companies grew to approximately $300 billion, while the Chinese government invested heavily in research centers, biotechnology hubs, and advanced scientific education.

The numbers tell an even more compelling story.

According to the continue reading …